For laboratory research use only. Not for human or veterinary use.

Research use only Pepmode Retatrutide 20 mg vial
Peptides

Retatrutide 20 mg

Also known as: LY3437943 · "Reta"

Retatrutide is a synthetic research peptide, also known by its development code LY3437943 and often shortened to "Reta". It is studied as a triple agonist — a single peptide designed to act on three receptors: GLP-1, GIP and glucagon. Pepmode supplies Retatrutide as a freeze-dried (lyophilised) powder for in-vitro laboratory research only.

$600 incl. GST · 10 vials · $60 per vial
In stock · Dispatched within 1–3 business days · FREE shipping on all orders
Pack size 20 mg per vial
Pack of 1010 vials × 20 mg Order up to 10 packs (100 vials)

For laboratory research use only. Not for human or veterinary use. You'll confirm research-only use at checkout.

Certificate of AnalysisBatch Download PDF
Stored 2–8 °C FREE shipping on all orders Secure card payment
Research overview

A closer look.

About this product

Each vial contains 20.71 mg net content and vials are sold in packs of 10. Every batch is tested by Axiombioanalytics with a reported purity of 99.16%. Certificates of Analysis are published on this page and in our CoA library, and updated as new testing is completed.

Store at 2–8 °C and protect from light. For laboratory research use only. Not for human or veterinary use.

Format
Lyophilised powder
Packs
10 vials
Product type
Research peptide
The research range

More research peptides

View all products
Pepmode BPC-157 10 mg vial BPC-157 10 mg Pack of 10 · $410 Pepmode Tesamorelin 10 mg vial Tesamorelin 10 mg Pack of 10 · $600 Pepmode Tirzepatide 10 mg vial Tirzepatide 10 mg Pack of 10 · $450 Pepmode Retatrutide 10 mg vial Retatrutide 10 mg Pack of 10 · $485